The manual resuscitators market was valued at USD 567.22 million in 2024 and is projected to reach USD 598.98 million in 2025 and USD 986.48 million by 2034, growing at a CAGR of 5.7% during the forecast period 2025–2034. Demand is driven by respiratory disorders, cardiac and neonatal emergencies, and expanding emergency medical services. Key players include Ambu A/S, CareFusion (Acquired by BD in 2014), Hopkins Medical Products (marketlab), HUM GmbH, Laerdal Medical, Medline Industries, LP, Medtronic Plc, PerSys Medical (Safeguard), ResMed, Teleflex Inc., VYAIRE, and WEINMANN Emergency Medical Technology GmbH + Co. KG.
Rising Respiratory Burden and Emergency Demand
The rising prevalence of chronic obstructive pulmonary disease, asthma, and other respiratory illnesses is driving demand. According to the CDC, COPD prevalence among adults was about 4.3% in 2023. Hospitals, EMS, and home healthcare providers are increasingly adopting these devices to improve outcomes. Application segmentation covers COPD, cardiopulmonary arrest, and others.
Cardiac arrest remains a serious public health issue. According to the American Heart Association's 2022 statistics, the U.S. records over 356,000 cases of out-of-hospital cardiac arrest annually, nearly 90% of which are fatal. Demand for portable, easy-to-use devices in out-of-hospital cardiac arrest scenarios is propelling the market and encouraging manufacturers to invest in innovation.
Pre-Hospital Care and Emergency Response
The expanding role of emergency response teams in pre-hospital care is fueling market expansion. Adoption of manual resuscitators by EMS providers, military medical units, and disaster response teams strengthens momentum. Demand is also supported by the expanding home healthcare sector and portable devices used in patient transport. Advancements in pre-hospital care and rising awareness of early intervention in respiratory emergencies reinforce North America's leading position.
Browse Full Insights:
https://www.polarismarketresearch.com/industry-analysis/manual-resuscitators-market
Care Settings: Hospitals, Ambulatory Surgical Centers, and NICUs
By end use, the market includes hospital, ASC, military, and others. Hospitals held the largest share in 2024 given the high volume of emergency and critical care procedures, availability of trained personnel, and advanced ICU infrastructure. Ambulatory surgical centers are expected to see significant growth as outpatient surgeries and ambulatory emergency care expand, with emphasis on minimally invasive surgeries and post-anesthesia recovery care. Favorable regulatory policies and healthcare investments support the growth of ambulatory surgical centers.
Stringent hospital protocols focused on patient safety and infection control have also fueled adoption of high-quality, disposable manual resuscitators.
Neonatal intensive care units are a key driver in Asia Pacific, where rising preterm births, pediatric respiratory distress, and chronic pulmonary diseases are prompting adoption of flow-inflating and self-inflating devices in neonatal intensive care units and emergency departments.
The growing presence of local and international medical device manufacturers, along with strategic partnerships to enhance distribution networks, is also fueling expansion in the region.
Safety Features, Regulation, and Investment
Innovations such as disposable self-inflating bags with safety valves and antimicrobial materials support demand. Pressure-limiting valves and bacterial filters improve patient outcomes, and ongoing product innovations include pressure-limiting valves in disposable designs. Stringent guidelines from the FDA, EMA, and WHO ensure high-quality devices, and rising healthcare expenditure supports emergency infrastructure; in January 2025, the New York Governor announced a preliminary investment of up to USD 188 million under the Healthcare Safety Net Transformation Program.
Regulatory mandates from organizations such as the FDA and AHA reinforce market value by enforcing stringent quality and safety standards for resuscitation devices.
Competitive Insights
Players pursue strategic investments, mergers and acquisitions, and joint ventures. In July 2025, Teleflex announced the acquisition of BIOTRONIK's Vascular Intervention business, highlighting industry consolidation. Medtronic and Teleflex both supply manual resuscitators, with Teleflex operating in over 40 countries. Smart-sensor integration and enhanced ergonomics present opportunities in hospital and home care settings.
More Trending Latest Reports By Polaris Market Research:
Gynecological Examination Chairs Market
Enterprise Content Management Market
AI Trust, Risk and Security Management Market